GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Cloughesy, T. F.; Alexander, B. M.; Berry, D. A.; Colman, H.; De Groot, J. F.; Ellingson, B. M.; Gordon, G. B.; Khasraw, M.; Lassman, A. B.; Lee, E. Q.; Lim, M.; Mellinghoff, I. K.; Nelli, A.; Perry, J. R.; Sulman, E. P.; Tanner, K.; Weller, M.; Wen, P. Y.; Yung, W. K. A. |
| Abstract Title: | GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304830 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS2078 |
| Notes: | Meeting Abstract: TPS2078 -- This meeting was also held virtually -- Source: Wos |
